SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 6-K/A
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of August 2019
Commission File Number: 001-36349
MediWound Ltd.
(Translation of registrant’s name into English)
42 Hayarkon Street
Yavne, 8122745 Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
CONTENTS
This amendment (the “Amendment”) to Mediwound Ltd.’s Form 6-K filed on August 14, 2019 (the “Original 6-K”)
revises Exhibit 99.1 of the Original 6-K to correct a typographical error regarding the date on which the extraordinary general meeting will be held that appears on the first page of the “Notice of extraordinary general meeting.” In the Original 6-K,
the Company incorrectly stated that the extraordinary general meeting would be held on September 23, 2019. This Amendment corrects that error and states, accurately, that the extraordinary general meeting will be held on September 26, 2019.
This error will not appear in any copy of the Notice of extraordinary general meeting and proxy statement that
is mailed to shareholders.
EXHIBIT INDEX
The following exhibits are furnished as part of this Form 6-K:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Mediwound Ltd.
|
|
|
|
|
|
Date: August 23, 2019
|
By:
|
/s/ Sharon Malka |
|
|
|
Name: Sharon Malka |
|
|
|
Title: Chief Executive Officer |
|
3